Published in PLoS One on September 25, 2015
Correction: Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses. PLoS One (2015) 0.75
Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research. Front Med (Lausanne) (2017) 0.75
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol (1993) 51.00
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A (1989) 18.26
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis. J Virol (2009) 4.14
The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins (1992) 3.44
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res (2001) 2.91
Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol (2006) 2.21
Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene (1992) 2.20
Genomics: massively parallel sequencing. Nature (2005) 2.05
Genetics of influenza viruses. Annu Rev Genet (2002) 1.88
Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs. Virology (1998) 1.60
Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A (1991) 1.52
Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine (1985) 1.49
A review of vaccine research and development: human enteric infections. Vaccine (2005) 1.46
The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine (2011) 1.44
Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33
Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine. J Virol (2001) 1.27
Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe (2013) 1.13
Detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides. J Virol Methods (2003) 1.06
Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines. Proc Natl Acad Sci U S A (2010) 1.04
Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A (2001) 0.99
Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J Virol (2001) 0.88
Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries. Vaccine (2011) 0.87
Trivalent intranasal influenza vaccine, live. Ann Pharmacother (2004) 0.87
Deep sequencing approach for genetic stability evaluation of influenza A viruses. J Virol Methods (2014) 0.82
Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines. Dev Biol Stand (1999) 0.81
Allele-specific PCR for quantitative analysis of mutants in live viral vaccines. J Virol Methods (2014) 0.78
Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33
Biomarkers in the age of omics: time for a systems biology approach. OMICS (2011) 1.13
Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis (2007) 0.98
Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s. Virology (2007) 0.93
Microarray assay for detection and discrimination of Orthopoxvirus species. J Med Virol (2006) 0.85
Algorithmic assessment of vaccine-induced selective pressure and its implications on future vaccine candidates. Adv Bioinformatics (2010) 0.84
Microarray-based assay for the detection of genetic variations of structural genes of West Nile virus. J Virol Methods (2008) 0.80
Environmental surveillance of viruses by tangential flow filtration and metagenomic reconstruction. Euro Surveill (2016) 0.76
MAPREC assay for quantitation of mutants in a recombinant flavivirus vaccine strain using near-infrared fluorescent dyes. J Virol Methods (2011) 0.76